Invention Grant
- Patent Title: Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy
-
Application No.: US17090797Application Date: 2020-11-05
-
Publication No.: US11242389B2Publication Date: 2022-02-08
- Inventor: Dina Schneider , Rimas J. Orentas , Boro Dropulic , Peirong Hu
- Applicant: Lentigen Technology, Inc.
- Applicant Address: US MD Gaithersburg
- Assignee: Lentigen Technology, Inc.
- Current Assignee: Lentigen Technology, Inc.
- Current Assignee Address: US MD Gaithersburg
- Agency: Fish & Richardson P.C.
- Agent Serge Sira, Esq.; Gregory J. Hwa, Esq.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K35/17 ; C07K14/725 ; C07K14/705 ; A61P35/02 ; A61K38/00
Abstract:
Chimeric antigen receptors containing CD19/CD22 or CD22/CD19 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.
Public/Granted literature
- US20210171633A1 Compositions and Methods for Treating Cancer with Anti-CD19/CD22 Immunotherapy Public/Granted day:2021-06-10
Information query
